SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?


To: 2MAR$ who wrote (9689)8/3/2001 10:02:53 AM
From: keithcray  Respond to of 208838
 
QLGC under $42, now.



To: 2MAR$ who wrote (9689)8/3/2001 10:06:40 AM
From: keithcray  Respond to of 208838
 
09:54 ET Genzyme (GENZ) 58.70 +1.02 (+1.8%): Announced this morning that company has received European Union approval to market Fabrazyme for long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease.